Alzheimer’s Disease/Dementia News

The Alzheimer’s Association announced the start of recruitment for the New IDEAS: Imaging Dementia — Evidence for Amyloid Scanning study, which aims to determine if amyloid PET scans improve diagnosis and treatment of Alzheimer’s disease.

Alzheimer’s disease and related dementias correlated with adverse financial events years before clinical diagnosis, according to findings published in JAMA Internal Medicine.

Patients with a history of traumatic brain injury experienced the clinical onset of Alzheimer’s disease several years earlier than those without TBI, data show.

In early November, the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee met to discuss a Biologics License Application for aducanumab, an anti-amyloid antibody in development for Alzheimer’s disease.

Rates and incidence of dementia among non-Hispanic Black individuals remained substantially higher compared with non-Hispanic white individuals in the U.S. from 2000 through 2016, according to findings published in JAMA Neurology.

Individuals with obstructive sleep apnea — especially severe obstructive sleep apnea — experienced an increased amyloid burden compared with controls, according to findings from a small study published in Journal of Alzheimer’s Disease.

COVID-19 survivors appeared at increased risk for psychiatric sequelae, according to results of an analysis of retrospective cohort studies published in The Lancet Psychiatry.

In this video, Jeffrey A. Sparks, MD, MMSc, associate physician at Brigham and Women's Hospital, highlighted data presented at ACR 2020 that investigated the incidence of dementia among patients with rheumatoid arthritis.

Researchers have detected plasma phosphorylated-tau217 in the preclinical stages of Alzheimer’s disease, indicating that this protein could be a biomarker for early disease pathology, according to findings published in JAMA Neurology.

Noncommunicable neurological disorders resulted in “a large and increasing burden” in the United States, according to a systematic analysis of the Global Burden of Disease study from 2017 that was published in JAMA Neurology.